Pivotal trials in blood cancers don’t mirror patient populationsSeptember 6, 2022Multiple MyelomaAMLDiversity in Medicine
Bias and other barriers to HSCT accessSeptember 1, 2022Multiple MyelomaTransplantMixed TopicsAMLMyelodysplastic Syndrome
Many die waiting for `last-chance’ therapyAugust 2, 2022Multiple MyelomaAggressive LymphomasALLCLLCellular TherapyMixed Topics
‘Extremely exciting’ study results guide MM treatment optionsJune 6, 2022Multiple MyelomaTransplantAMLMyelodysplastic SyndromeMixed Topics
Ex–hospital porter a neglected giant of cancer researchMay 11, 2022ALLAggressive LymphomasB Cell LymphomaCLLDLBCLMantle Cell LymphomaMultiple Myeloma
Repurposed drug could revolutionize stem cell transplantationMarch 18, 2022TransplantB Cell LymphomaHodgkin LymphomaMultiple MyelomaPediatricsDLBCLCLL
FDA approves new CAR T-cell treatment for multiple myelomaMarch 1, 2022Multiple MyelomaCellular Therapy
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'January 21, 2022TransplantAggressive LymphomasALLDLBCLCLLTranslational ResearchB Cell Lymphoma
DKMS: Small nonprofit to world’s largest stem cell donor registryJanuary 21, 2022ALLCOVID-19 UpdatesMixed TopicsMultiple MyelomaDLBCLB Cell LymphomaAML
